SNN Stock Overview
Develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Smith & Nephew plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£25.70 |
| 52 Week High | UK£31.72 |
| 52 Week Low | UK£23.65 |
| Beta | 0.69 |
| 1 Month Change | 1.62% |
| 3 Month Change | 0.63% |
| 1 Year Change | -8.41% |
| 3 Year Change | -21.14% |
| 5 Year Change | -49.06% |
| Change since IPO | 211.51% |
Recent News & Updates
Smith & Nephew Getting No Credit For Self-Improvement Efforts ... But Should It?
Jan 29Smith & Nephew: Ready To Reap Demographic, Turnaround Dividends
Nov 10Recent updates
Smith & Nephew Getting No Credit For Self-Improvement Efforts ... But Should It?
Jan 29Smith & Nephew: Ready To Reap Demographic, Turnaround Dividends
Nov 10Smith & Nephew Delivering On Its Turnaround Promise
Aug 22Smith & Nephew: Work To Be Done But Still Long-Term Potential
Jun 12Smith & Nephew: Orthopedics Growth Continues To Drive Sales Forward
Dec 28Smith & Nephew Getting More Interesting As A Contrarian Idea
Oct 12Smith & Nephew: Entering New Markets But Growth Is Slow Still
Aug 01Smith & Nephew reports FY earnings; initiates FY23 guidance
Feb 21Smith & Nephew: Potential Only Has Value If You Can Execute
Dec 14Smith & Nephew: Still A Buy Despite Short-Term Challenges
Sep 26Smith & Nephew 1H 2022 Earnings Preview
Jul 27Smith+Nephew launches app Wound Compass to help reduce variation in wound care
Jul 12Smith & Nephew: Fair Price For An Attractive Medical Devices Supplier
Jun 01Smith & Nephew: Valuation Looking More Attractive
Jan 26Smith & Nephew Is A Premium Brand That Should Deliver Something Special
Nov 06Smith & Nephew Leveraged To Post-Pandemic Normalization And Self-Help
Sep 02Smith & Nephew plc: Improving Performance Reflected In Price
Jun 18Smith & Nephew: Pandemic Long Tail Reduces Attractiveness
Jan 14Smith & Nephew: A Long-Term Buy And Hold In Medical Devices
Nov 09Shareholder Returns
| SNN | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 4.2% | 0.7% | 1.5% |
| 1Y | -8.4% | 13.0% | 22.4% |
Return vs Industry: SNN underperformed the US Medical Equipment industry which returned 12.9% over the past year.
Return vs Market: SNN underperformed the US Market which returned 22.2% over the past year.
Price Volatility
| SNN volatility | |
|---|---|
| SNN Average Weekly Movement | 2.8% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 18.0% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SNN has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: SNN's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1856 | 18,000 | Deepak Nath | www.smith-nephew.com |
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
Smith & Nephew plc Fundamentals Summary
| SNN fundamental statistics | |
|---|---|
| Market cap | US$11.26b |
| Earnings (TTM) | US$305.00m |
| Revenue (TTM) | US$5.64b |
36.9x
P/E Ratio2.0x
P/S RatioIs SNN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SNN income statement (TTM) | |
|---|---|
| Revenue | US$5.64b |
| Cost of Revenue | US$1.67b |
| Gross Profit | US$3.97b |
| Other Expenses | US$3.66b |
| Earnings | US$305.00m |
Last Reported Earnings
Jun 29, 2024
Next Earnings Date
Feb 25, 2025
| Earnings per share (EPS) | 0.35 |
| Gross Margin | 70.33% |
| Net Profit Margin | 5.41% |
| Debt/Equity Ratio | 66.7% |
How did SNN perform over the long term?
See historical performance and comparisonDividends
2.9%
Current Dividend Yield107%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/16 12:36 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/06/29 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Smith & Nephew plc is covered by 56 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christoph Gubler | Bank Vontobel AG |
| Hassan Al-Wakeel | Barclays |
| Sally Taylor | Barclays |